foropafant has been researched along with Colitis, Ulcerative in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawkey, CJ; Jenkins, D; Stack, WA; Vivet, P | 1 |
1 trial(s) available for foropafant and Colitis, Ulcerative
| Article | Year |
|---|---|
Lack of effectiveness of the platelet-activating factor antagonist SR27417A in patients with active ulcerative colitis: a randomized controlled trial. The Platelet Activating Factor Antagonist Study Group in Ulcerative Colitis.
Topics: Adult; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Thiazoles | 1998 |